← Insider buys
KITE

Kite Pharma, Inc.

VP, Product Sciences Marc Better sold $426K of Kite Pharma, Inc.

Sold$426,036
$47.34Price
9,000Shares
−54%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Feb 1. Filed Wed, Feb 3, 2:04 PM ET, during the session. Not investment advice.